TNF and hepatosplenic T-cell lymphoma: The onset of B-cell lineage lymphomas and hepatosplenic T cell lymphoma (HSTCL) has been observed in patients with Crohn’s disease who received anti-TNF-α agents mainly in association to thiopurines [33–35].